טוען...
Ethnic differences in thromboprophylaxis for COVID-19 patients: should they be considered?
Thromboembolic events contribute to morbidity and mortality in coronavirus disease 2019 (COVID-19). As a result, thromboprophylaxis using low-molecular-weight heparin (LMWH) is universally recommended for hospitalized patients based on multiple guidelines. However, ethnic differences with respect to...
שמור ב:
| הוצא לאור ב: | Int J Hematol |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Springer Singapore
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7816059/ https://ncbi.nlm.nih.gov/pubmed/33471294 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12185-021-03078-x |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|